+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Ventilator Market: Regulatory Landscape, Analysis and Forecast, 2021-2030

  • ID: 5094216
  • Report
  • May 2020
  • Region: Global
  • 278 Pages
  • BIS Research
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Air Liquide
  • Ford Motor Company
  • Getinge AB
  • Medtronic plc
  • ResMed
  • Ventec Life Systems
  • MORE

Market Report Coverage - Ventilator Market - Regulatory Landscape

Market Segmentation

  • Product Type - Intensive Care Ventilator and Portable Ventilator
  • Modality - Invasive Ventilation and Non-Invasive Ventilation
  • Patient Age - Adult and Pediatric and Neonates
  • End User - Hospitals and Specialty Clinics, Emergency Medical Services, and Homecare

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, Rest-of-Europe
  • Asia-Pacific - China, Japan, India, South Korea, Singapore, Australia and New Zealand, Rest-of-Asia-Pacific
  • Rest-of-the-World - Latin America, Middle East and Africa

Growth Drivers

  • Increasing Respiratory Disease Incidences
  • Rising Geriatric Population
  • Increase in Number of ICU Beds
  • High Number of Premature Births
  • Government and Organizational Initiatives to Boost Ventilator Production

Market Challenges

  • Complications and Side-Effects Associated with Ventilator Usage
  • Lack of Trained Medical Staff

Market Opportunities

  • Coronavirus Outbreak Leading to Rising Global Ventilator Demand
  • Increasing Requirement of Portable Ventilators for Homecare and Emergency Usage
  • Development of Digital Education and Training Tool

Key Healthcare and Non-Healthcare Companies Profiled

Aerobiosys Innovations Private Limited, Air Liquide, Drägerwerk AG & Co. KGaA, General Electric Company, Getting AB, Hamilton Medical, Koninklijke Philips N.V., Löwenstein Medical Innovation GmbH & Co. KG, Medtronic plc, OneBreath Inc., Penlon Ltd, ResMed, SCHILLER, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Smiths Group plc, Ventec Life Systems, Ventinova Medical, VYAIRE MEDICAL,INC., WEINMANN Emergency Medical Technology GmbH + Co. KG, ZOLL Medical Corporation

Non-Healthcare Companies

Dyson Ltd, Ford Motor Company, General Motors Company, Maruti Suzuki India Limited and Virgin Orbit

Key Questions Answered:

  • Which country has the maximum number of installed bases of ventilators in the year 2019, and why?
  • What are the major regulatory changes taking place in the global ventilator market pre-COVID-19, during COVID-19, and post-COVID-19? How are these changes expected to impact the global ventilator market in the future?
  • How is the industry expected to evolve during the forecast period 2021-2030?
  • What will be the impact on the products that have been awarded emergency use authorization (EUA) during the COVID-19 pandemic, once the pandemic is over?
  • How has the supply and demand of the ventilator changed during the COVID-19 phase in contrast to the pre-COVID-19 phase?
  • What is the market value estimates of the leading segments of the global ventilator market in 2030?
  • What is the change witnessed in the growth rate of the global ventilator market from pre-COVID to post-COVID scenario?
  • What are the major driving factors, challenges, and opportunities for the global ventilator market? What will be the impact of these factors once the COVID-19 pandemic is over?
  • What is the growth potential of the global ventilator market in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
  • What impact of large ventilator inventories on the global ventilator market is expected once the COVID-19 pandemic is over?

Market Overview

In 2019, the annual global demand for the ventilators was 82,500. However, the accelerated spread of COVID-19 and rising severity of the cases globally has propelled the global demand for ventilators by 5.6 times, up to 413,000, by the end of 2020. To cope with the rising demand for ventilators, regulatory bodies across different regions, such as the Food and Drug Administration (FDA), Health Canada, and Therapeutics Goods Administration (TGA), have taken unprecedented steps. For instance, in March 2020 FDA declared COVID-19 pandemic as a public emergency and authorized anesthesia gas machines, continuous positive airway pressure (CPAP), and other sleep apnea devices as alternative ventilators under emergency use authorization (EUA). Furthermore, in April 2020, the TGA published a document stating the minimum requirements to be met by medical devices to be used as alternative ventilators.

Moreover, the regulatory bodies are also revamping ventilator supply chains to limit the supply shortage constraints. For instance, under the Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency guidelines, the FDA has authorized the usage of alternative materials for making ventilator tubing. Furthermore, the FDA has also approved modifications to ventilator motor so that other suppliers can manufacture it.

The healthcare experts are continuously analyzing the impact of regulatory and industrial decisions on the global ventilator market. Moreover, the global market for ventilators is predicted to grow at an exponential CAGR of 176% by the end of 2020. However, a significant dip is expected in 2021 owing to the overproduction of ventilators and stockpiling of the device. The market is anticipated to normalize from 2022. The market is driven by certain factors, which include the rising incidence of respiratory diseases, high rate of premature births, rising demand for critical care in the geriatric population, and government initiatives for boosting the ventilator production.

The market is favored by the development of low-cost ventilator products and partnerships between healthcare and non-healthcare companies for scaling up the ventilator production.

Within the research report, the market is segmented based on product type, modality, patient age, end user, and regional analysis. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Air Liquide
  • Ford Motor Company
  • Getinge AB
  • Medtronic plc
  • ResMed
  • Ventec Life Systems
  • MORE

Executive Summary

1 Product Definition

2 Research Scope
2.1 Research Scope
2.2 Exclusion Criteria of the Report
2.3 Key Questions Answered by the Research Study

3 Report Methodology
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Market Estimation Model
3.4 Data Sources Categorization
3.5 Selection Criteria for Company Profiles
3.6 Assumptions and Limitations

4 Market Overview
4.1 Overview of Ventilators
4.2 Global Installed Base of the Ventilators
4.3 Global Ventilator Market Scenario

5 Industry Analysis
5.1 Patent Analysis
5.1.1 Patent Filling Trend, Pre-COVID Phase (January 2015-March 2020)
5.2 Regulatory Framework and Government Initiatives
5.2.1 Comparison of the Pre-COVID-19 and Post-COVID-19 Regulations
5.2.1.1 Regulations in North America
5.2.1.1.1 Food and Drug Administration (FDA)
5.2.1.1.2 Health Canada
5.2.1.2 Regulations in Europe
5.2.1.3 Regulations in Asia-Pacific
5.2.1.3.1 National Medical Products Administration (NMPA)
5.2.1.3.2 Pharmaceutical and Medical Device Agency (PMDA)
5.2.1.3.3 The Central Drug Standard Control Organization (CDSCO)
5.2.1.3.4 Therapeutic Goods Administration (TGA)
5.2.1.3.5 Health Science Authority (HSA)
5.2.1.4 Regulations in Latin America
5.2.2 Emergency Use Authorization (EUA)
5.3 Supply and Demand Analysis
5.3.1 Global Supply and Demand
5.3.1.1 Pre-COVID
5.3.1.2 Post-COVID
5.3.2 Component Supply Chain
5.3.3 Tear-Down Analysis of Ventilator Costing

6 Global Ventilator Market Sizing and Forecast
6.1 Market Dynamics
6.1.1 Growth Promoting Factors
6.1.1.1 Increasing Respiratory Disease Incidences
6.1.1.2 Rising Geriatric Population
6.1.1.3 Increase in Number of ICU Beds
6.1.1.4 High Number of Premature Births
6.1.1.5 Government and Organizational Initiatives to Boost Ventilator Production
6.1.2 Growth Inhibiting Factors
6.1.2.1 Complications and Side-Effects Associated with Ventilators Usage
6.1.2.2 Lack of Trained Medical Staff
6.2 Impact Analysis
6.3 Growth Opportunities
6.3.1 Coronavirus Outbreak Leading to Rising Global Ventilator Demand
6.3.2 Increasing Requirement of Portable Ventilators for Homecare and Emergency Usage
6.3.3 Development of Digital Education and Training Tool

7 Global Ventilator Market (by Product Type)
7.1 Intensive Care Ventilator
7.2 Portable Ventilator

8 Global Ventilator Market (by Modality)
8.1 Non-Invasive Ventilation
8.2 Invasive Ventilation/Mechanical Ventilation

9 Global Ventilator Market (by Patient Age)
9.1 Pediatric and Neonates
9.2 Adult

10 Global Ventilator Market (by End User)
10.1 Hospitals and Specialty Clinics
10.2 Emergency Medical Services
10.3 Homecare

11 Global Ventilator Market (by Region)
11.1 North America Ventilator Market
11.1.1 North America Ventilator Market (by Product Type)
11.1.2 North America Ventilator Market (by Modality)
11.1.3 North America Ventilator Market (by Patient Age)
11.1.4 North America Ventilator Market (by End User)
11.1.5 North America Ventilator Market (by Country)
11.1.5.1 U.S.
11.1.5.1.1 U.S. Ventilator Market (by Product Type)
11.1.5.1.2 U.S. Ventilator Market (by Modality)
11.1.5.1.3 U.S. Ventilator Market (by Patient Age)
11.1.5.1.4 U.S. Ventilator Market (by End User)
11.1.5.2 Canada
11.1.5.2.1 Canada Ventilator Market (by Product Type)
11.1.5.2.2 Canada Ventilator Market (by Modality)
11.1.5.2.3 Canada Ventilator Market (by Patient Age)
11.1.5.2.4 Canada Ventilator Market (by End User)
11.2 Europe Ventilator Market
11.2.1 Europe Ventilator Market (by Product Type)
11.2.2 Europe Ventilator Market (by Modality)
11.2.3 Europe Ventilator Market (by Patient Age)
11.2.4 Europe Ventilator Market (by End User)
11.2.5 Europe Ventilator Market (by Country)
11.2.5.1 Germany
11.2.5.1.1 Germany Ventilator Market (by Product Type)
11.2.5.1.2 Germany Ventilator Market (by Modality)
11.2.5.1.3 Germany Ventilator Market (by Patient Age)
11.2.5.1.4 Germany Ventilator Market (by End User)
11.2.5.2 The U.K.
11.2.5.2.1 The U.K. Ventilator Market (by Product Type)
11.2.5.2.2 The U.K. Ventilator Market (by Modality)
11.2.5.2.3 The U.K. Ventilator Market (by Patient Age)
11.2.5.2.4 The U.K. Ventilator Market (by End User)
11.2.5.3 France
11.2.5.3.1 France Ventilator Market (by Product Type)
11.2.5.3.2 France Ventilator Market (by Modality)
11.2.5.3.3 France Ventilator Market (by Patient Age)
11.2.5.3.4 France Ventilator Market (by End User)
11.2.5.4 Italy
11.2.5.4.1 Italy Ventilator Market (by Product Type)
11.2.5.4.2 Italy Ventilator Market (by Modality)
11.2.5.4.3 Italy Ventilator Market by (Patient Age)
11.2.5.4.4 Italy Ventilator Market (by End User)
11.2.5.5 Spain
11.2.5.5.1 Spain Ventilator Market (by Product Type)
11.2.5.5.2 Spain Ventilator Market (by Modality)
11.2.5.5.3 Spain Ventilator Market (By Patient Age)
11.2.5.5.4 Spain Ventilator Market (by End User)
11.2.5.6 Rest-of-Europe
11.2.5.6.1 Rest-of-Europe Ventilator Market (by Product Type)
11.2.5.6.2 Rest-of-Europe Ventilator Market (by Modality)
11.2.5.6.3 Rest-of-Europe Ventilator Market (by Patient Age)
11.2.5.6.4 Rest-of-Europe Ventilator Market (by End User)
11.3 Asia-Pacific Ventilator Market
11.3.1 Asia-Pacific Ventilator Market (by Product Type)
11.3.2 Asia-Pacific Ventilator Market (by Modality)
11.3.3 Asia-Pacific Ventilator Market (by Patient Age)
11.3.4 Asia-Pacific Ventilator Market (by End User)
11.3.5 Asia-Pacific Ventilator Market, (by Country)
11.3.5.1 China
11.3.5.1.1 China Ventilator Market (by Product Type)
11.3.5.1.2 China Ventilator Market (by Modality)
11.3.5.1.3 China Ventilator Market (by Patient Age)
11.3.5.1.4 China Ventilator Market (by End User)
11.3.5.2 Japan
11.3.5.2.1 Japan Ventilator Market (by Product Type)
11.3.5.2.2 Japan Ventilator Market (by Modality)
11.3.5.2.3 Japan Ventilator Market (by Patient Age)
11.3.5.2.4 Japan Ventilator Market (by End User)
11.3.5.3 India
11.3.5.3.1 India Ventilator Market (by Product Type)
11.3.5.3.2 India Ventilator Market (by Modality)
11.3.5.3.3 India Ventilator Market (by Patient Age)
11.3.5.3.4 India Ventilator Market (by End User)
11.3.5.4 South Korea
11.3.5.4.1 South Korea Ventilator Market (by Product Type)
11.3.5.4.2 South Korea Ventilator Market (by Modality)
11.3.5.4.3 South Korea Ventilator Market (by Patient Age)
11.3.5.4.4 South Korea Ventilator Market (by End User)
11.3.5.5 Singapore
11.3.5.5.1 Singapore Ventilator Market (by Product Type)
11.3.5.5.2 Singapore Ventilator Market (by Modality)
11.3.5.5.3 Singapore Ventilator Market (by Patient Age)
11.3.5.5.4 Singapore Ventilator Market (by End User)
11.3.5.6 Australia and New Zealand
11.3.5.6.1 Australia and New Zealand Ventilator Market (by Product Type)
11.3.5.6.2 Australia and New Zealand Ventilator Market (by Modality)
11.3.5.6.3 Australia and New Zealand Ventilator Market (by Patient Age)
11.3.5.6.4 Australia and New Zealand Ventilator Market (by End User)
11.3.5.7 Rest-of-Asia-Pacific
11.3.5.7.1 Rest-of-Asia-Pacific Ventilator Market (by Product Type)
11.3.5.7.2 Rest- of -Asia-Pacific Ventilator Market (by Modality)
11.3.5.7.3 Rest-of-Asia-Pacific Ventilator Market (by Patient Age)
11.3.5.7.4 Rest-of-Asia-Pacific Ventilator Market (by End User)
1 1.4 Rest-of-the-World Ventilator Market
11.4.1 Rest-of-the-World Ventilator Market (by Product Type)
11.4.2 Rest-of-the-World Ventilator Market (by Modality)
11.4.3 Rest-of-the-World Ventilator Market (by Patient Age)
11.4.4 Rest-of-the-World Ventilator Market (by End User)

12 Company Profiles
12.1 Aerobiosys Innovations Private Limited
12.1.1 Company Overview
12.1.2 Role of Aerobiosys Innovations Private Limited in the Global Ventilator Market
12.1.3 Aerobiosys Innovations Private Limited in the COVID-19 Scenario
12.2 Air Liquide
12.2.1 Company Overview
12.2.2 Role of Air Liquide in the Global Ventilator Market
12.2.3 Recent Developments
12.2.4 Air Liquide Healthcare in the COVID-19 Scenario
12.3 Drägerwerk AG & Co. KGaA
12.3.1 Company Overview
12.3.2 Role of Drägerwerk AG & Co. KGaA in the Global Ventilator Market
12.3.3 Recent Developments
12.3.4 Drägerwerk AG & Co. KGaA in the COVID-19 Scenario
12.4 General Electric Company
12.4.1 Company Overview
12.4.2 Role of General Electric Company in the Global Ventilator Market
12.4.3 Recent Developments
12.4.4 GE Healthcare in the COVID-19 Scenario
12.5 Getinge AB
12.5.1 Company Overview
12.5.2 Role of Getinge AB in the Global Ventilator Market
12.5.3 Recent Developments
12.5.4 Getinge AB in the COVID-19 Scenario
12.6 Hamilton Medical
12.6.1 Company Overview
12.6.2 Role of Hamilton Medical in the Global Ventilator Market
12.6.3 Recent Developments
12.6.4 Hamilton Medical in the COVID-19 Scenario
12.7 Koninklijke Philips N.V
12.7.1 Company Overview
12.7.2 Role of Koninklijke Philips N.V.in the Global Ventilator Market
12.7.3 Recent Developments
12.7.4 Koninklijke Philips N.V. in the COVID-19 Scenario
12.8 Löwenstein Medical Innovation GmbH & Co. KG
12.8.1 Company Overview
12.8.2 Role of Löwenstein Medical Innovation GmbH & Co. KG in the Global Ventilator Market
12.8.3 Recent Development
12.8.4 Löwenstein Medical Innovation GmbH & Co. KG in the COVID-19 Scenario
12.9 Medtronic plc
12.9.1 Company Overview
12.9.2 Role of Medtronic plc in the Global Ventilator Market
12.9.3 Recent Developments
12.9.4 Medtronic plc in the COVID-19 Scenario
12.10 OneBreath Inc.
12.10.1 Company Overview
12.10.2 Role of OneBreath Inc. in the Global Ventilator Market
12.10.3 Recent Developments
12.10.4 OneBreath Inc. in the COVID-19 Scenario
12.11 Penlon Ltd
12.11.1 Company Overview
12.11.2 Role of Penlon Ltd in the Global Ventilator Market
12.11.3 Recent Developments
12.11.4 Penlon Ltd in the COVID-19 Scenario
12.12 ResMed
12.12.1 Company Overview
12.12.2 Role of ResMed. in the Global Ventilator Market
12.12.3 Recent Developments
12.12.4 ResMed in the COVID-19 Scenario
12.13 SCHILLER
12.13.1 Company Overview
12.13.2 Role of SCHILLER in the Global Ventilator Market
12.14 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
12.14.1 Company Overview
12.14.2 Role of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. in the Global Ventilator Market
12.14.3 Recent Developments
12.14.4 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
12.15 Smiths Group plc
12.15.1 Company Overview
12.15.2 Role of Smiths Group plc in the Global Ventilator Market
12.15.3 Smiths Medical, Inc. in the COVID-19 Scenario
12.16 Ventec Life Systems
12.16.1 Company Overview
12.16.2 Role of Ventec Life Systems in the Global Ventilator Market
12.16.3 Recent Developments
12.16.4 Ventec Life Systems in the COVID-19 Scenario
12.17 Ventinova Medical
12.17.1 Company Overview
12.17.2 Role of Ventinova Medical in the Global Ventilator Market
12.17.3 Recent Developments
12.17.4 Ventinova Medical in the COVID-19 Scenario
12.18 VYAIRE MEDICAL, INC.
12.18.1 Company Overview
12.18.2 Role of VYAIRE MEDICAL, INC. in the Global Ventilator Market
12.18.3 Recent Developments
12.18.4 VYAIRE MEDICAL, INC. in the COVID-19 Scenario
12.19 WEINMANN Emergency Medical Technology GmbH + Co. KG
12.19.1 Company Overview
12.19.2 Role of WEINMANN Emergency Medical Technology GmbH + Co. KG in the Global Ventilator Market
12.19.3 Recent Developments
12.19.4 WEINMANN Emergency Medical Technology GmbH + Co. KG in the COVID-19 Scenario
12.20 ZOLL Medical Corporation
12.20.1 Company Overview
12.20.2 Role of ZOLL Medical Corporation in the Global Ventilator Market
12.20.3 Recent Developments:
12.20.4 ZOLL Medical Corporation in the COVID-19 Scenario
12.21 Non-Healthcare Companies
12.21.1 Dyson Ltd.
12.21.1.1 Company Overview
12.21.1.2 Role of Dyson Ltd. in the Global Ventilator Market in the COVID-19 Scenario
12.21.2 Ford Motor Company
12.21.2.1 Company Overview
12.21.2.2 Role of Ford Motor Company in the Global Ventilator Market in the COVID-19 Scenario
12.21.3 General Motors Company
12.21.3.1 Company Overview
12.21.3.2 Role of General Motor Company in the Global Ventilator Market in the COVID-19 Scenario
12.21.4 Maruti Suzuki India Limited
12.21.4.1 Company Overview
12.21.4.2 Role of Maruti Suzuki India Limited in the Global Ventilator Market in the COVID-19 Scenario
12.21.5 Virgin Orbit (Subsidiary of Virgin Group)
12.21.5.1 Company Overview
12.21.5.2 Role of Virgin Orbit in Global Ventilator Market in the COVID-19 Scenario

List of Tables
Table 5.1: European Commission Medical Device Directives
Table 5.2: Federal Agencies of EU Member States
Table 5.3: Regulatory Bodies in Asia-Pacific
Table 5.4: Traditional and New Source of Component Supply Chain
Table 5.5: Price Range and Manufacturers of Ventilator Components
Table 6.1: Number of ICU beds in the U.S. (Year-wise)
Table 6.2: Top Ten Countries with Highest Premature Births in 2018
Table 12.1: Key Features and Price Range of Aerobiosys Innovations Private Limited Ventilator
Table 12.2: Key Features and Price Range of Air Liquide Healthcare Ventilators
Table 12.3: Key Features and Price Range of Drägerwerk AG & Co. KGaA Ventilators
Table 12.4: Key Features and Price Range of GE Healthcare Ventilator
Table 12.5: Key Features and Price Range of Getinge AB Ventilators
Table 12.6: Key Features and Price Range of Hamilton Medical Ventilators
Table 12.7: Key Features and Price Range of Koninklijke Philips N.V. Ventilators
Table 12.8: Key Features and Price Range of Löwenstein Medical Innovation GmbH & Co. KG Ventilators
Table 12.9: Key Features and Price Range of Medtronic plc Ventilators
Table 12.10: Key Features and Price Range of OneBreath Inc. Ventilator
Table 12.11: Key Features and Price Range of Penlon Ltd Ventilators
Table 12.12: Key Features and Price Range of ResMed. Ventilators
Table 12.13: Key Features and Price Range of SCHILLER Ventilators
Table 12.14: Key Features and Price Range of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Ventilators
Table 12.15: Key Features and Price Range of Smiths Medical, Inc. Ventilator
Table 12.16: Key Features and Price Range of Ventec Life Systems Ventilator
Table 12.17: Key Features and Price Range of Ventinova Medical Ventilators
Table 12.18: Key Features and Price Range of VYAIRE MEDICAL, INC. Ventilators
Table 12.19: Key Features and Price Range of WEINMANN Emergency Medical Technology GmbH + Co. KG Ventilators
Table 12.20: Key Features and Price Range of ZOLL Medical Corporation Ventilators

List of Figures
Figure 1: Global Ventilator Market (Pre-COVID-19), 2019-2030
Figure 2: Global Ventilator Market (Post-COVID-19), 2019-2030
Figure 3: Growth Promoting and Growth Inhibiting Factors of Global Ventilator Market
Figure 4: Global Ventilator Market: Regulatory Landscape
Figure 5: Global Ventilator Market: Patent Analysis (by Year of Filling, January 2015-March 2020
Figure 6: Global Ventilator Market (Product Type), 2019 and 2030
Figure 7: Global Ventilator Market (by Modality), 2019 and 2030
Figure 8: Global Ventilator Market (by End User), 2019 and 2030
Figure 9: Global Ventilator Market (by Region), 2019
Figure 2.1: Global Ventilator Market Segmentation
Figure 3.1: Global Ventilator Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.5: Top-Down Approach (Segment-Wise Analysis)
Figure 3.6: Total Number of Healthcare Company Profiles
Figure 3.7: Total Number of Non-Healthcare Company Profiles
Figure 3.8: Assumptions and Limitations
Figure 4.1: Coronavirus (Spread, Symptoms, Susceptibility, Preventive Measures)
Figure 4.2: Installed Base of Ventilators, 2019
Figure 4.3: Global Availability of Ventilators Per Million Population, 2019
Figure 4.4: Market Landscape of Global Ventilator Market
Figure 5.1: Global Ventilator Market: Patent Analysis (by Year of Filling,  January 2015-March 2020)
Figure 5.2: Risk Assessment of Medical Devices
Figure 5.3: Global Ventilator Market: Regulatory Landscape
Figure 5.4: FDA Regulatory Pathway for Medical Device
Figure 5.5: FDA Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
Figure 5.6: Health Canada Regulatory Pathway for Medical Device
Figure 5.7: Health Canada Regulations Modification: Pre-COVID-19 Phase to Post  COVID-19 Phase
Figure 5.8: EU Regulatory Pathway for Medical Device
Figure 5.9: European Commission Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
Figure 5.10: NMPA Regulatory Pathway for Medical Device
Figure 5.11: NMPA Regulations Modification: Pre-COVID-19 Phase to  Post-COVID-19 Phase
Figure 5.12: PMDA Regulatory Pathway for Medical Device
Figure 5.13: PMDA Regulations Modification: Pre-COVID-19 Phase to  Post-COVID-19 Phase
Figure 5.14: CDSCO Regulatory Pathway for Medical Device
Figure 5.15: CDSCO Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
Figure 5.16: TGA Regulatory Pathway for Medical Device
Figure 5.17: TGA Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
Figure 5.18: HSA Regulatory Pathway for Medical Device
Figure 5.19: HSA Regulations Modification: Pre-COVID-19 Phase to Post-COVID-19 Phase
Figure 5.20: Emergency Use Procedures During COVID-19
Figure 5.21: Value Chain for Ventilators
Figure 5.22: Demand-Supply Gap in Ventilators (by June End)
Figure 6.1: Prevalence of COPD and Asthma in Key Countries, 2015-2017
Figure 6.2: Rising Number of Respiratory Infections in the COVID-19 Pandemic
Figure 6.3: Pre-COVID-19 and Post-COVID-19 Demand Surge of Ventilators
Figure 6.4: Geriatric Population (60 years and above) Worldwide in Different Regions, 2000, 2015, 2030, and 2050
Figure 6.5: Post-COVID Impact on Geriatric Population
Figure 6.6: Capacity Gap of ICU Beds Post-COVID-19
Figure 6.7: Regulatory Scenario in Pre-COVID-19 and Post-COVID-19 Situation
Figure 6.8: Scenario of Ventilator-Associated Pneumonia in Pre-COVID-19 and During-COVID
Figure 6.9: Scenario of Trained Medical Staff in Pre-COVID-19 and During-COVID-19
Figure 6.10: Impact Analysis: Growth Promoting Factors and Inhibiting Factors
Figure 6.11: Impact on Mortality Rate with Respect to Ventilator Availability
Figure 6.12: Features and Benefits of Ventilator Training Alliance Universal Platform
Figure 7.1: Global Ventilator Market (by Product Type)
Figure 7.2: Global Ventilator Market (by Product Type) 2019-2030
Figure 7.3: Global Intensive Care Ventilator Market, 2019-2030
Figure 7.4: Global Portable Ventilator Market, 2019-2030
Figure 8.1: Global Ventilator Market (by Modality)
Figure 8.2: Global Ventilator Market (by Modality), 2019-2030
Figure 8.3: Global Non-Invasive Ventilation Market, 2019-2030
Figure 8.4: Global Invasive/Mechanical Ventilation Market, 2019-2030
Figure 9.1: Global Ventilator Market (by Patient Age)
Figure 9.2: Global Ventilator Market (by Patient Age), 2019-2030
Figure 9.3: Global Ventilator Market for Pediatric and Neonates, 2019-2030
Figure 9.4: Global Ventilator Market for Adult, 2019-2030
Figure 10.1: Global Ventilator Market (by End User)
Figure 10.2: Global Ventilator Market (by End User), 2019-2030
Figure 10.3: Global Ventilator Market in Hospitals and Speciality Clinics, 2019-2030
Figure 10.4: Global Ventilator Market in Emergency Medical Services, 2019-2030
Figure 10.5: Global Ventilator Market in Homecare, 2019-2030
Figure 11.1: Global Ventilator Market (by Region), 2019
Figure 11.2: Regional Analysis of the Global Ventilator Market, 2019-2030
Figure 11.3: North America Ventilator Market, 2019-2030
Figure 11.4: North America: Market Dynamics
Figure 11.5: North America Ventilator Market (by Product Type), 2019-2030
Figure 11.6: North America Ventilator Market (by Modality), 2019-2030
Figure 11.7: North America Ventilator Market (by Patient Age), 2019-2030
Figure 11.8: North America Ventilator Market (by End User), 2019-2030
Figure 11.9: North America Ventilator Market (by Country), 2019 and 2030
Figure 11.10: U.S. Ventilator Market, 2019-2030
Figure 11.11: FDA Action Timeline for COVID-19
Figure 11.12: U.S. Ventilator Market (by Product Type), 2019-2030
Figure 11.13: U.S. Ventilator Market (by Modality), 2019-2030
Figure 11.14: U.S. Ventilator Market (by Patient Age), 2019-2030
Figure 11.15: U.S. Ventilator Market (by End User), 2019-2030
Figure 11.16: Canada Ventilator Market, 2019-2030
Figure 11.17: Canada Ventilator Market (by Product Type), 2019-2030
Figure 11.18: Canada Ventilator Market (by Modality), 2019-2030
Figure 11.19: Canada Ventilator Market (by Patient Age), 2019-2030
Figure 11.20: Canada Ventilator Market (by End User), 2019-2030
Figure 11.21: Europe Ventilator Market, 2019-2030
Figure 11.22: Europe: Market Dynamics
Figure 11.23: Europe Ventilator Market (by Modality), 2019-2030
Figure 11.24: Europe Ventilator Market (by Patient Age), 2019-2030
Figure 11.25: Europe Ventilator Market (by End User), 2019-2030
Figure 11.26: Europe Ventilator Market (by Country), 2019 and 2030
Figure 11.27: Germany Ventilator Market, 2019-2030
Figure 11.28: Germany Ventilator Market (by Product Type), 2019-2030
Figure 11.29: Germany Ventilator Market (by Modality), 2019-2030
Figure 11.30: Germany Ventilator Market (by Patient Age), 2019-2030
Figure 11.31: Germany Ventilator Market (by End User), 2019-2030
Figure 11.32: U.K.: Ventilator Market, 2019-2030
Figure 11.33: MHRA Action Timeline Amidst COVID-19 Pandemic
Figure 11.34: The U.K. Ventilator Market (by Product Type), 2019-2030
Figure 11.35: The U.K. Ventilator Market (by Modality), 2019-2030
Figure 11.36: The U.K. Ventilator Market (by Patient Age), 2019-2030
Figure 11.37: The U.K. Ventilator Market (by End User), 2019-2030
Figure 11.38: France: Ventilator Market, 2019-2030
Figure 11.39: France Ventilator Market (by Product Type), 2019-2030
Figure 11.40: France Ventilator Market (by Modality), 2019-2030
Figure 11.41: France Ventilator Market (by Patient Age), 2019-2030
Figure 11.42: France Ventilator Market (by End User), 2019-2030
Figure 11.43: Italy: Ventilator Market, 2019-2030
Figure 11.44: Italy Ventilator Market (by Product Type), 2019-2030
Figure 11.45: Italy Ventilator Market (by Modality), 2019-2030
Figure 11.46: Italy Ventilator Market (by Patient Age), 2019-2030
Figure 11.47: Italy Ventilator Market (by End User), 2019-2030
Figure 11.48: Spain: Ventilator Market, 2019-2030
Figure 11.49: Spain Ventilator Market (by Product Type), 2019-2030
Figure 11.50: Spain Ventilator Market (by Modality), 2019-2030
Figure 11.51: Spain Ventilator Market (by Patient Age), 2019-2030
Figure 11.52: Spain Ventilator Market (by End User), 2019-2030
Figure 11.53: Rest-of-Europe: Ventilator Market, 2019-2030
Figure 11.54: Rest-of-Europe Ventilator Market (by Product Type), 2019-2030
Figure 11.55: Rest-of-Europe Ventilator Market (by Modality), 2019-2030
Figure 11.56: Rest-of-Europe Ventilator Market (by Patient Age), 2019-2030
Figure 11.57: Rest-of-Europe Ventilator Market (by End User), 2019-2030
Figure 11.58: Asia-Pacific Ventilator Market, 2019-2030
Figure 11.59: Asia-Pacific: Market Dynamics
Figure 11.60: Asia-Pacific Ventilator Market (by Product Type), 2019-2030
Figure 11.61: Asia-Pacific Ventilator Market (by Modality), 2019-2030
Figure 11.62: Asia-Pacific Ventilator Market (by Patient Age), 2019-2030
Figure 11.63: Asia-Pacific Ventilator Market (by End User), 2019-2030
Figure 11.64: Asia-Pacific Ventilator Market (by Country), 2019 and 2030
Figure 11.65: China Ventilator Market, 2019-2030
Figure 11.66: China Ventilator Market (by Product Type), 2019-2030
Figure 11.67: China Ventilator Market (by Modality), 2019-2030
Figure 11.68: China Ventilator Market (by Patient Age), 2019-2030
Figure 11.69: China Ventilator Market (by End User), 2019-2030
Figure 11.70: Japan Ventilator Market, 2019-2030
Figure 11.71: Japan Ventilator Market (by Product Type), 2019-2030
Figure 11.72: Japan Ventilator Market (by Modality), 2019-2030
Figure 11.73: Japan Ventilator Market (by Patient Age), 2019-2030
Figure 11.74: Japan Ventilator Market (by End User), 2019-2030
Figure 11.75: India Ventilator Market, 2019-2030
Figure 11.76: Regulatory Workflow for Importing Medical Devices
Figure 11.77: India Ventilator Market (by Product Type), 2019-2030
Figure 11.78: India Ventilator Market (by Modality), 2019-2030
Figure 11.79: India Ventilator Market (by Patient Age), 2019-2030
Figure 11.80: India Ventilator Market (by End User), 2019-2030
Figure 11.81: South Korea Ventilator Market, 2019-2030
Figure 11.82 South Korea Ventilator Market (by Product Type), 2019-2030
Figure 11.83 South Korea Ventilator Market (by Modality), 2019-2030
Figure 11.84 South Korea Ventilator Market (by Patient Age), 2019-2030
Figure 11.85 South Korea Ventilator Market (by End User), 2019-2030
Figure 11.86: Singapore Ventilator Market, 2019-2030
Figure 11.87: Singapore Ventilator Market (by Product Type), 2019-2030
Figure 11.88: Singapore Ventilator Market (by Modality), 2019-2030
Figure 11.89: Singapore Ventilator Market (by Patient Age), 2019-2030
Figure 11.90: Singapore Ventilator Market (by End User), 2019-2030
Figure 11.91: Australia and New Zealand Ventilator Market, 2019-2030
Figure 11.92: Australia and New Zealand Ventilator Market (by Product Type), 2019-2030
Figure 11.93: Australia and New Zealand Ventilator Market (by Modality), 2019-2030
Figure 11.94: Australia and New Zealand Ventilator Market (by Patient Age), 2019-2030
Figure 11.95: Australia and New Zealand Ventilator Market (by End User), 2019-2030
Figure 11.96: Rest-of-Asia-Pacific Ventilator Market, 2019-2030
Figure 11.97: Rest-of-Asia-Pacific Ventilator Market (by Product Type), 2019-2030
Figure 11.98: Rest-of-Asia-Pacific Ventilator Market (by Modality), 2019-2030
Figure 11.99: Rest-of-Asia-Pacific Ventilator Market (by Patient Age), 2019-2030
Figure 11.100: Rest-of-Asia-Pacific Ventilator Market (by End User), 2019-2030
Figure 11.101: Rest-of-the-World Ventilator Market, 2019-2030
Figure 11.102: Rest-of-the-World: Market Dynamics
Figure 11.103: Rest-of-the-World Ventilator Market (by Product Type), 2019-2030
Figure 11.104: Rest-of-the-World Ventilator Market (by Modality), 2019-2030
Figure 11.105: Rest-of-the-World Ventilator Market (by Patient Age), 2019-2030
Figure 11.106: Rest-of-the-World Ventilator Market (by End User), 2019-2030
Figure 12.1: Aerobiosys Innovations Private Limited: Overall Product Portfolio
Figure 12.2: Air Liquide: Overall Product Portfolio
Figure 12.3: Drägerwerk AG & Co. KGaA: Overall Product Portfolio
Figure 12.4: GE Healthcare: Overall Product Portfolio
Figure 12.5: Getinge AB: Overall Product Portfolio
Figure 12.6: Hamilton Medical: Overall Product Portfolio
Figure 12.7: Koninklijke Philips N.V.: Overall Product Portfolio
Figure 12.8: Löwenstein Medical Innovation GmbH & Co. KG: Overall Product Portfolio
Figure 12.9: Medtronic plc: Overall Product Portfolio
Figure 12.10: OneBreath Inc.: Overall Product Portfolio
Figure 12.11: Penlon Ltd: Overall Product Portfolio
Figure 12.12: ResMed.: Overall Product Portfolio
Figure 12.13: SCHILLER: Overall Product Portfolio
Figure 12.14: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: Overall Product Portfolio
Figure 12.15: Smiths Group plc.: Overall Product Portfolio
Figure 12.16: Ventec Life Systems.: Overall Product Portfolio
Figure 12.17: Ventinova Medical: Overall Product Portfolio
Figure 12.18: VYAIRE MEDICAL, INC.: Overall Product Portfolio
Figure 12.19: WEINMANN Emergency Medical Technology GmbH + Co. KG: Overall Product Portfolio
Figure 12.20: ZOLL Medical Corporation: Overall Product Portfolio

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Air Liquide
  • Ford Motor Company
  • Getinge AB
  • Medtronic plc
  • ResMed
  • Ventec Life Systems
  • MORE

According to this market intelligence report, titled “Global Ventilator Market – Regulatory Landscape, Analysis and Forecast, 2021-2030”, the global ventilator market was valued at $1,142.0 million in 2019 and has witnessed a growth surge of up to 172% in 2020 due to the rise in demand pertaining to the coronavirus outbreak. Moreover, the market is anticipated to normalize from 2022 and grow consistently with a CAGR of 15.13% during the forecast period 2021-2030.

The exponential rise in respiratory infections due to coronavirus pandemic has accelerated the demand for ventilators globally. To ensure adequate ventilator supply, various regulatory agencies across North America, Europe, Asia-Pacific, and Latin America have modified their regulations and approval process for ventilators. Furthermore, the regulatory agencies have also approved several devices under the emergency use authorization (EUA) provision. Additionally, various healthcare and non-healthcare companies have revamped their production lines to meet the surging demand of the ventilators.

According to Abdul Wahid, Principal Consultant, “In a pre-COVID scenario, the market was expected to grow the compound annual growth rate (CAGR) of 7.1%. However, the COVID-19 pandemic has resulted in an extensive rise in ventilator demand and has increased the growth rate by up to 172% and revenue to $3,110 million. However, owing to the production of ventilators and global stockpiling of the medical device the market is expected to witness a significant dip in 2021, and growth is expected from 2022. The COVID-19 pandemic is anticipated to have a prolonged effect on the global ventilator market. Owing to the pandemic, the market registered growth with a CAGR of 15.13% (post-COVID-19) in comparison to the CAGR of 7.48% that was anticipated for the pre-COVID-19 global ventilator market during 2021-2030”

Research Highlights:

  • The largest installed base of the ventilators is in the U.S., and the region still has a requirement of an additional 85,000 ventilators to cope with the situation of the COVID-19 pandemic.
  • The global regulatory landscape pertaining to the ventilators has undergone significant alterations due to the pandemic. Several companies such as Medtronic Plc, Beijing Aeonmed Co, Ltd, Shenzen Mindray Biomedical Electronics, Vyaire Medical Inc., ResMed, Philips Respironics (Subsidiary of Koninklijke Philips N.V.), Dragerwerk AG & CO. KGaA and GE Healthcare have been awarded EUA owing to the COVID-19 pandemic
  • While the global ventilator market is anticipated to witness significant growth, the absence of trained clinical staff would remain a major restraint for the market. Furthermore, the market has the opportunity for expansion in portable ventilators and digital education and training segment.
  • Europe’s ventilator market is anticipated to witness significant growth owing to the rising incidences and increasing manufacturing of the ventilators.
  • Various government and industrial organizations in Middle East and Africa have revamped their production lines for manufacturing ventilators.  
  • The market has witnessed increased production form various healthcare companies. Furthermore, owing to the pandemic various start-ups have also emerged as key players. Non-healthcare companies across different industry verticals have also developed novel ventilator prototypes and are assisting healthcare companies in increasing ventilator production.

This market intelligence report provides a multi-dimensional view of the global ventilator market in terms of the product type, modality, patient age, end user, and regional analysis. This research report aims at answering the changing dynamics of the global ventilator market and the key companies penetrating the market along with their opportunities and challenges that can determine the overall growth of the market in upcoming years.

The regulatory landscape chapter of the report encompasses the risk assessment and the modified regulations for various agencies across North America, Europe, Asia-Pacific, and Latin America owing to the pandemic. The chapter also highlights the emergency use authorizations (EUA). Moreover, within the research report, the market is segmented based on product type, modality, patient age, end user and regional analysis. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained

Note: Product cover images may vary from those shown
5 of 5
  • Aerobiosys Innovations Private Limited
  • Air Liquide
  • Drägerwerk AG & Co. KGaA
  • Dyson Ltd.
  • Ford Motor Company
  • General Electric Company
  • General Motors Company
  • Getinge AB
  • Hamilton Medical
  • Koninklijke Philips N.V.
  • Löwenstein Medical Innovation GmbH & Co. KG
  • Maruti Suzuki India Limited
  • Medtronic plc
  • OneBreath Inc.
  • Penlon Ltd
  • ResMed
  • SCHILLER
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Smiths Group plc
  • VYAIRE MEDICAL, INC.
  • Ventec Life Systems
  • Ventinova Medical
  • Virgin Orbit (Subsidiary of Virgin Group)
  • WEINMANN Emergency Medical Technology GmbH + Co. KG
  • ZOLL Medical Corporation
Note: Product cover images may vary from those shown
Adroll
adroll